Aytu Biopharma, Inc
AYTU
Revenue
17.98M
▼-17.00k▼-0.09448%
3 Months ChangeAssets
118.10M
▼-10.77M▼-8.36%
3 Months ChangeLiabilities
100.72M
▲3.62M▲3.72%
3 Months ChangeFree Cash Flow
-2.99M
▼-237.27k▼-8.63%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001437749-24-030297
2024-09-26
Form 8-K
ID: 0001437749-24-030075
2024-08-06
Form 8-K
ID: 0001437749-24-024725
2024-06-26
Form 8-K
ID: 0001437749-24-021296
2024-06-18
Form 8-K
ID: 0001437749-24-020590
2024-05-15
Form 8-K
ID: 0001437749-24-017058
2024-05-15
Form 10-Q
ID: 0001437749-24-017051
2024-02-14
Form 8-K
ID: 0001437749-24-004155
2024-02-14
Form 10-Q
ID: 0001437749-24-004149
2023-11-17
Form 8-K
ID: 0001558370-23-019194